Plus: Rejoni secures FDA approval, Taiwan sees demand for fertility services, and Neuroelectrics co-founder joins EU-Startups Summit.
Biotia extended its Series A, taking total reported funding to $19.4 million for tackling diagnostic gaps in recurrent UTIs, indicating expanding investment in precision diagnostics for clinicians. Rejoni secured FDA approval for its Juveena hydrogel, marking a significant regulatory milestone for menopause care providers. Concurrently, reproductive restrictions in China are sending women across the Strait to freeze their eggs, increasing demand for fertility services at IVF clinics. Five takes inside, plus a quick-hits roundup.
VIA FutureFemHealth
Rejoni’s Juveena hydrogel secured FDA approval, following Rejoni's $25 million raise in June to prepare for approval and commercial launch. Biotia raised $9 million, extending its Series A to $19.4 million for tackling diagnostic gaps in recurrent UTIs. Flouria reached €1.5 million in funding after serving more than 1,000 women in its first year. The NIH awarded up to $9.26 million as part of a $21 million hormone research initiative to build predictive models of vaginal tissue changes.
Read the full story →
— The Luteal Editorial Team
VIA EU-Startups
Neuroelectrics secured €15 million ($17.5 million) in Series A funding in 2021, led by Morningside Ventures. The company used the capital to advance its non-invasive brain stimulation platform and clinical programs for epilepsy and depression. Ana Maiques, co-founder and CEO of Neuroelectrics, will deliver a keynote titled 'From European Innovation to Global Scale: Lessons from Neurotech' at the EU-Startups Summit 2027 in Malta on May 13-14. Neuroelectrics’ technologies, which combine neuroscience and machine learning for brain monitoring and stimulation, are currently present in more than 74 countries. Femtech operators and investors should note Maiques's advocacy for women in STEM as she showcases scaling a neurotech company.
Read the full story →
— The Luteal Editorial Team
VIA FT Health
Reproductive restrictions in China send women across the Strait to freeze their eggs. This trend highlights a demand for fertility services in regions with fewer restrictions.
Read the full story →
— The Luteal Editorial Team
VIA PR Newswire – Health
Vitamin Angels will share new research at the 2026 Micronutrient Forum. Vitamin Angels has worked with governments and partners to advance nutrition programs since 2018. The organization has over 30 years of experience in maternal and child nutrition. This highlights ongoing efforts in maternal health research and program implementation.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
Jean Cunningham, PharmD, BCPS, explains how ob-gyns can link anxiety, sleep disruption, and cognitive changes to perimenopause. This expert insight can help ob-gyns identify perimenopause earlier.
Read the full story →
— The Luteal Editorial Team